Prospective Longitudinal Evaluation of Vaginal Stenosis and Sexual Function in Women With Pelvic Malignancies Treated With and Without Pelvic Radiation Therapy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 8
- 试验地点
- 1
- 主要终点
- Observation of a change in vaginal length as measured with a vaginal sound (modified vaginal dilator)
研究概览
简要总结
This study evaluates the effects of treatment with a vaginal dilator to reduce vaginal stenosis in women receiving pelvic radiation therapy for pelvic malignancies.
详细描述
Vaginal stenosis can occur as a result of treatment for pelvic malignancies. Women receiving pelvic radiation therapy using a vaginal dilator 5-7 times per week will have less vaginal stenosis than women using a vaginal dilator fewer times or not at all.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Pre and post menopausal women undergoing definitive (not palliative) treatments for a pelvic malignancy, including rectal, endometrial, cervical, or anal canal carcinoma.
- •Treatments include radiation therapy, chemotherapy, surgery, or a combination of therapies.
- •May have early-stage or locally advanced (node positive) disease.
- •Male partners of the female subjects are also consented for this study.
排除标准
- •Subject may not have evidence of metastatic disease.
- •Prior pelvic radiation therapy
- •Prior hysterectomy (not for current diagnosis)
- •Diagnosis of prior malignancy, except non-melanoma skin cancer.
结局指标
主要结局
Observation of a change in vaginal length as measured with a vaginal sound (modified vaginal dilator)
时间窗: Up to 24 Months
Observation of change in vaginal length will be measured at baseline (which for the patients in the radiation group will be prior to any pelvic radiation therapy and for patients in the surgery group this will be at the first post-operative visit), as well as in follow-up visits at 3, 6, 12, and 24 months for a total of 5 measurements.
Observation of change in sexual function/satisfaction as measured by the Sexual Adjustment Questionnaire (SAQ)
时间窗: Up to 24 Months
The baseline SAQ will be administered prior to radiation therapy for the pelvic malignancy group and it will be administered at the post-operative visit for the surgery only group, and the post-treatment SAQ version will be given at the follow-up visits at 3, 6, 12, and 24 months for a total of 5 measurements.
次要结局
未报告次要终点